ImmuPharma PLC is a pharmaceutical development company listed since 2006 on AIM of the London Stock Exchange (LSE:IMM). The company is focusing on developing novel medicines with high sales potential in specialist markets with serious unmet need. ImmuPharma has five drug candidates in development, two platform technologies and approximately 70 patents.

01 01 dr francisco ortega
Dr. Robert Zimmer
01 02 dr daniel ortega
Dra. Fanny Valleix